Endo International plc, et al.
Case Number:
7:22-bk-22549
Court:
Nature of Suit:
Firms
- Akin Gump
- Alston & Bird
- ArentFox Schiff
- ASK LLP
- Barton LLP
- Beck Chaet
- Bielli & Klauder
- Binder & Schwartz
- Blank Rome
- Bond Schoeneck
- Brown & Connery
- Brown Rudnick
- Carter Ledyard
- Chiesa Shahinian
- Chipman Brown
- Cohen Weiss
- Connell Foley
- Cooley LLP
- Covington & Burling
- Cullen & Dykman
- Davidson Bowie
- Davidson Fink
- Davis Polk
- Dickie McCamey
- Duane Morris
- Fishman Haygood
- Fleischer Fleischer
- Foley & Lardner
- Foran Glennon
- Fox Rothschild
- FrankGecker
- Frejka PLLC
- Freshfields
- Gibson Dunn
- Glenn Agre
- Godfrey & Kahn
- Goldman Ismail
- Haynes & Boone
- Herzfeld Suetholz
- Hodgson Russ
- Husch Blackwell
- Jenner & Block
- Jones Day
- Katten Muchin
- Kelley Drye
- Kenney Shelton
- Kirkland & Ellis
- Klehr Harrison
- Klestadt Winters
- K&L Gates
- Kline & Specter
- Kohner Mann
- Kramer Levin
- Kurzman Eisenberg
- Latham & Watkins
- Levenfeld Pearlstein
- Linebarger Goggan
- Locke Lord
- Mayer Brown
- McCarter & English
- McElroy Deutsch
- McGrail & Bensinger
- Miller Nash LLP
- Nelson Mullins
- Nixon Peabody
- Norton Rose
- Obermayer Rebmann
- O'Melveny & Myers
- Orrick Herrington
- Paul Weiss
- Perkins Coie
- Phillips Lytle
- Pillsbury Winthrop
- Porzio Bromberg
- Potter Anderson
- Pullman & Comley
- Ross Smith & Binford
- Rubin LLC
- Saul Ewing
- Schiller Knapp
- Seward & Kissel
- Shipman & Goodwin
- Sills Cummis
- Skadden Arps
- Squire Patton
- Stark & Stark
- Stevens & Lee
- Stranch Jennings
- Stutzman Bromberg
- Taft Stettinius
- Tarter Krinsky
- Togut Segal
- Troutman Pepper
- Tucker Arensberg
- Wachtell Lipton
- Warner Norcross
- Weltman Weinberg
- White & Case
- Willkie Farr
- WilmerHale
- Young Conaway
Companies
- AbbVie Inc.
- Altaris Capital Partners LLC
- Alvarez & Marsal Holdings LLC
- American Federation of State County & Municipal Employees
- AstraZeneca PLC
- Berkeley Research Group LLC
- Cardinal Health Inc.
- Cencora Inc.
- Collegium Pharmaceutical Inc.
- Computershare Ltd.
- Consolidated Edison Inc.
- Constellation Energy Corp.
- Cornerstone Research Inc.
- CVS Health Corp.
- DTE Energy Co.
- Ducera Partners LLC
- Dundon Advisers LLC
- Endo International PLC
- Ernst & Young LLP
- Evidera
- Evoqua Water Technologies LLC
- Express Scripts Holding Co.
- Ford Motor Co.
- Glenmark Pharmaceuticals Ltd.
- Grant Thornton LLP
- Grunenthal Group
- Henry Schein Inc.
- Jefferies Financial Group Inc.
- Johnson Controls International PLC
- Johnson & Johnson
- KPMG International
- Lazard Ltd.
- Lexington Insurance Co.
- Liberty Mutual Insurance Group
- Life Technologies Corporation
- McKesson Corp.
- Medco Health Solutions Inc.
- Merck & Co. Inc.
- Novitium Pharma LLC
- Optum Inc.
- OptumRx Inc.
- Oracle Corp.
- Patheon Inc.
- PCI Pharma Services
- PECO Energy Co.
- Pfizer Inc.
- PricewaterhouseCoopers LLP
- Province LLC
- SAP AG
- SAS Institute Inc.
- Teikoku Pharma USA Inc.
- Teva Pharmaceutical Industries Ltd.
- The Cigna Group
- The Hartford Financial Services Group Inc.
- Thermo Fisher Scientific Inc.
- Toyota Industries Commercial Finance Inc.
- UMB Financial Corp.
- United BioSource Corp.
- United Steelworkers
- U.S. Bancorp
- Walmart Inc.
- Wilmington Trust Corp.
Government Agencies
- Missouri Department of Revenue
- National Labor Relations Board
- Rochester City School District
- State of Indiana
Sectors & Industries:
-
August 18, 2022
Endo Noteholders Say Alternative Ch. 11 Plan Needed
Creditors of Endo International told a New York bankruptcy judge Thursday that they will seek to file an alternative to Endo's proposed Chapter 11 sale, as the drugmaker made its first court appearance in its bankruptcy case.
-
August 17, 2022
Ch. 11 Cheat Sheet: Endo International PLC
Besieged by opioid crisis lawsuits, drugmaker Endo International has filed for Chapter 11 protection in a New York bankruptcy court, saying a deal will cut $6 billion in debt and earmark $550 million for claims it contributed to an epidemic of narcotic abuse.
-
August 17, 2022
Endo Hits Ch. 11 Amid Opioid Suit Crush
Besieged by opioid crisis lawsuits, drugmaker Endo International has filed for Chapter 11 protection in a New York bankruptcy court, saying a deal will cut $6 billion in debt and earmark $550 million for claims it contributed to an epidemic of narcotic abuse.
- ← Previous
- 1
- 2
- 3
- Next →